co-chaperone ͉ motor proteins ͉ protein stability P roteins with Unc-45-/CRO1-/She4p-related (UCS) domains have been implicated in the folding, assembly and functions of myosin motor proteins in animals and fungi. In addition to a C-terminal UCS domain (1), all of these proteins have a central domain (conserved in animals, but not in yeast) and animal UCS proteins have an N-terminal tetratricopeptide (TPR) domain. Unc-45 from Caenorhabditis elegans, the first UCS protein to be characterized, is required for assembly of myosin-II in muscle (2) and cytokinesis (3). Loss of Unc-45 function results in reduced myosin-II levels in muscle because of ubiquitin-mediated degradation by proteasomes (4). Unc-45 binds Hsp90 (via its TPR domain) and the myosin-II motor (via its UCS domain) (5) and is proposed to act as a cochaperone ensuring the folding of myosin motors (1, 5, 6). The action of UCS proteins is not restricted to myosin-II. The budding yeast UCS protein, She4p, acts on type I myosins Myo3p and Myo5p, and type V myosin, Myo4p (7, 8). The fission yeast UCS protein, Rng3p (9), interacts with myosin-II (Myo2p) via its UCS domain (10). Purified Myo2 has actin-activated ATPase activity, but requires Rng3p to move actin filaments effectively in the presence of ATP (10). Rng3p is also required for fission yeast to assemble and constrict the contractile ring of actin filaments and Myo2p during cytokinesis (9).
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Here, we report experiments with fission yeast Rng3p and budding yeast She4p to investigate the contributions of UCS proteins to de novo folding of myosins and motor activity of folded myosins. Both the N-terminal ''central'' and UCS domains of Rng3p are required for function in vivo and to enhance interaction of Myo2 with actin filaments in the presence of ATP. Deletion of the gene for the single budding yeast UCS protein, She4p, reduces cellular levels of the type I myosin Myo5p, owing to faster turn over, but Myo5p isolated from she4⌬ cells is soluble and biochemically active. Thus, yeast UCS proteins contribute to both the stability and function of myosin motors.
Results

Rng3p Associates with Assembling and Mature Contractile Rings.
Rng3p-3YFP concentrated in precursors of the contractile ring (nodes) in temperature-sensitive myo2-E1 mutant cells grown at a permissive temperature of 23°C (Fig. 1A) . These cells overexpress Rng3p (11) and concentrate it in contractile rings (9) . In wild-type cells, Rng3p-3YFP is only detected some time after nodes have condensed into mature rings (10) . Accumulation of Rng3p in mature contractile rings did not rely on the septation initiation network (SIN), which triggers ring constriction late in mitosis (12) . Rng3p-3xYFP was found in unconstricted rings of arrested temperature-sensitive sid2-250 cells (data not shown) lacking a functional SIN at the restrictive temperature (13) .
Both the Central and UCS Domain of Rng3p Are Required for Function in Vivo.
To test the independent functions of the Rng3p Nterminal central and C-terminal UCS domains in vivo, we made GFP-fusion constructs of each domain. 3GFP-Rng3p rescued the temperature-sensitivity of rng3-65 cells and concentrated weakly in contractile rings of wild-type cells compared with its strong concentration in rings of myo2-E1 cells ( Fig. 1 B and C) . Whereas neither truncated form of Rng3p complemented the temperature-sensitivity of the rng3-65 strain (Fig. 1B) , 3GFP-UCS concentrated prominently in nodes and contractile rings of both myo2-E1 and wild-type cells (Fig. 1C) . 3GFP-central concentrated in highly constricted rings of myo2-E1 cells but not in wild-type cells (Fig. 1C) . The average diameter of 3GFP-central rings was 1.1 m (range 0.5-2 m), much smaller than the maximum diameter (Ϸ4.5 m).
Purification of Functional Myo2
Motor Domains. Acquiring isolated Myo2 motor domains was appealing, because they are expected to be soluble in physiological concentrations of salt like muscle myosin subfragment-1. This solubility was essential for the detailed characterization of muscle myosin ATPase kinetics (14) and crystal structures (15) .
To purify a soluble form of Myo2 (Myo2-head-GST) from fission yeast we co-overexpressed a truncated form of Myo2p (amino acids 1-815, Myo2p motor plus light chain domain) with cleavable GST-tags on both light chains and a permanent C-terminal GST-tag on the heavy chain. Given the dimeric nature of GST, the soluble construct has two myosin heads, each with two light chains. GST facilitates attachment of the myosin heads to cover-slips for in vitro motility assays (16) . Fig. 2A summarizes the purification, which yields Ϸ2 mg of purified Myo2-head-GST from 8-liter of culture. Actin filaments stimulated the steady-state Mg-ATPase activities of both Myo2 (fulllength Myo2p plus light chains) and Myo2-head-GST (Fig. 2B) Table S1 ) and Myo2-head-GST ( Fig. 3 C and D and Table S1 ) for actin filaments, measured by a reproducible 1.5 to 2-fold reduction in K ATPase values. Rng3p did not increase the maximum ATPase activity of either Myo2 or Myo2-head-GST (Table S1) .
ATP-dependent actin filament gliding in vitro depends on the presence of Rng3p when the slide is coated with low concentrations of Myo2, but not when the slide was coated with high concentrations of Myo2. At thresholds Ͼ750 nM Myo2 (or 500 nM Myo2-head-GST), actin filaments bound to the slides and moved without Rng3p (Fig. 3E ). The gliding rates were 0.4 m/sec for all concentrations of Myo2 and 0.2 m/sec for all concentrations of Myo2-head-GST (Table S1 ).
In the presence of ATP Rng3p promoted binding of actin filaments to Myo2 on the slide surface ( Fig. 3 F-H ). This effect of Rng3p allowed relatively low concentrations of Myo2 (100 nM) to support gliding movements of actin filaments (Fig. 3F ). Although gliding rates did not change, the number of actin filaments bound to slides coated with Myo2 increased with the concentration of Rng3p (Fig. 3 F and G) . The ATP concentration was an important variable in experiments with low concentrations of Myo2 on the slide. At low ATP concentrations, Myo2 bound but did not move actin filaments (Fig. 3H) . At physio- Representative head-GST samples taken during the purification are indicated (left to right): head-GST affinity purified by enrichment of GST-tagged light chains/head on glutathioneSepharose; thrombin-treated head (removes GST from light chains); head-GST pelleted by cosedimentation with actin filaments in the absence of ATP; soluble head-GST recovered by resuspending the actin-head-GST pellet in the presence of ATP followed by a second round of actin filament pelleting; purified head-GST after removal of residual actin by rebinding of head-GST to glutathione Sepharose. (B) Head-GST (circles) and Myo2 (squares) actinactivated Mg 2ϩ -ATPase activity shown as a function of polymerized actin concentration. Basal head-GST and Myo2 ATPase activities generated from control reactions (lacking actin filaments) were subtracted from all rates derived in the presence of polymerized actin (0.5-100 M based on the concentration of polymerized actin subunits). All assays included myosin at a final concentration of 200 nM in 2 mM Tris⅐HCl (pH 7.2), 10 mM imidazole, 100 mM KCl, 0.1 mM CaCl 2, 3 mM MgCl2, 2 mM ATP, and 1 mM DTT. Each curve was generated from average values obtained from five different datasets and fit to Michaelis-Menten kinetics, using KaleidaGraph software.
logical concentrations of ATP, Rng3p was required for Myo2 to support actin filament binding and motility (Fig. 3H) .
The Rng3p UCS domain was less active than full-length Rng3p in activating Myo2 motility. Although 0.5 M Rng3p effectively increased filament binding by low and high concentrations of Myo2, higher concentrations of Rng3p UCS domain (Ϸ2 M) were needed to activate motility ( Fig. 3F ) by enhancing the number of filaments bound by Myo2 (Fig. 3G ). The effect of Rng3p UCS domain is likely nonspecific considering its failure to enhance Myo2 actin activated ATPase activity ( Fig. 3B ) and our observation that high concentrations of BSA (equivalent to Rng3p concentrations Ͼ10 M) can enhance actin filament binding in motility assays with either Myo2 or Myo2-head. Given that the Rng3p UCS domain associates with Myo2p (10), the GST-UCS construct represents a negative control for motility experiments involving full-length Rng3p.
In contrast, neither full-length Rng3p nor the Rng3p UCS domain showed any sign of activating motility at low concentrations (100 nM) of Myo2-head-GST (Fig. 3F ). Furthermore, with high concentrations of Myo2-head-GST (1 M), neither Rng3p nor the Rng3p UCS domain increased the number of filaments bound to the surface (Fig. 3G ).
Isolation of Functional Myo2 from a rng3 Mutant Strain. Our reconstitution experiments showing that Rng3p stimulates the motility activity of enzymatically active Myo2 do not rule out a role for Rng3p in the de novo folding of Myo2 in cells (1, 5, 6 ). An ideal approach to test whether Rng3p is required for Myo2 folding would be to characterize Myo2 from a rng3⌬ strain. However, given that loss of rng3 is lethal, we induced overexpression of Myo2 in a rng3-65 temperature-sensitive strain grown under both permissive (25°C) and restrictive (36°C) conditions. At both temperatures, we recovered 3-to 4-fold less Myo2 from rng3-65 cells than from wild-type cells (Fig. 4) . Overexpressed Myo2p heavy chains were ubiquitinated to the same degree in wild-type and rng3-65 cells (Fig. 4) . Myo2 from rng3-65 cells (induced at 25 or 36°C) supported in vitro motility (Table S1 ), showing that . Basal ATPase activities were subtracted from all rates derived in the presence of polymerized actin (0.5-100 M). All assays included myosin at a final concentration of 200 nM (Ϯ800 nM GST-Rng3p/-UCSp) in 2 mM Tris⅐HCl (pH 7.2), 10 mM imidazole, 100 mM KCl, 0.1 mM CaCl 2, 3 mM MgCl2, 2 mM ATP, and 1 mM DTT. For each curve, three separate datasets were averaged and displayed as a single dataset that was fit to Michaelis-Menten kinetics, using KaleidaGraph software. Activities measured in the presence of GST-Rng3p (or GST-UCS) were always recorded in unison with corresponding measurements lacking GST-Rng3p or GST-UCS. (E) The ability of head-GST and Myo2 to support binding and in vitro motility of actin filaments in 1 mM ATP is plotted as a function of the myosin concentration applied to motility chambers. (F and G) The ability of head-GST and Myo2 to support in vitro motility is plotted as a function of GST-Rng3p or GST-UCS concentration. (F) Head-GST and Myo2 were delivered into chambers at a low concentration (100 nM) that does not support filament binding and motility. (G) Head-GST and Myo2 were delivered into chambers at a high concentration (1 M) that supports filament motility. The number of filaments bound by myosin at the cover-slip surface was averaged by using four 130-m 2 frames taken from fluorescence micrographs from two independent experiments. Average filament numbers are plotted as relative values, with 1 being equal to the number of filaments bound in the absence of GST-Rng3p or GST-UCS. (H) The relative number of actin filaments (where 1 represents the highest recorded value) bound by Myo2 were plotted as a function of the ATP concentration in the running buffer (small filled squares, 50 nM Myo2 alone; small filled circles, 50 nM Myo2 plus 500 nM GST-Rng3p). Filament numbers were quantitated and averaged as described in G. The rate at which Myo2-bound actin filaments move in these assays is also displayed as a function of ATP concentration (large open squares, 50 nM Myo2 alone; large open circles, 50 nM Myo2 plus 500 nM GST-Rng3p). Myo2p and its GSTtagged light chains were overexpressed and 1-step purified from wild-type (MLP 509) and rng3-65 (MLP 586) cells in which the myo2 promoter was replaced with the nmt41 (medium-strength) inducible promoter. Myo2 expression was induced for 22 h at 25°C followed by further induction for 4 h at 25°C or 36°C. Samples purified in one-step by affinity chromatography on glutathione-Sepharose were run on SDS/PAGE gels, transferred to nitrocellulose, and probed with anti-Myo2p tail antibodies to compare levels of Myo2p. The blot was stripped with 4% trichloroacetic acid and reprobed with antiubiquitin antibodies to compare levels of Myo2p ubiquitination. Samples were prepared identically and the volumes loaded on gels normalized based on the relative protein concentrations of soluble lysed cell extracts. cells can produce functional Myo2 when Rng3p function is compromised.
Effect of the Budding Yeast UCS Protein on the Cellular Levels and
Activities of Myosin-I. To characterize myosin in the complete absence of its respective UCS protein we turned to budding yeast, which has a single nonessential UCS gene, SHE4 (17) . She4p is required for the function of type I myosins (Myo3p and Myo5p), and one type V (Myo4p) myosin (7, 8) , but cells are viable (albeit temperature-sensitive) without She4p. For visualization and isolation we replaced the MYO5 gene with MYO5-GFP or MYO5-GST under the control of the native promoter in both wild-type and she4⌬ cells (18) .
The steady-state amount of Myo5-GST in cell extracts was Ϸ10-fold lower in she4⌬ cells than wild-type cells (Fig. 5 A-C , E, and F) owing to much faster turnover of the newly synthesized protein (Fig. 6C) . We carried out pulse-chase experiments in she4⌬ cells and wild-type cells with the genomic promoter for MYO5 replaced with an inducible GAL1 promoter. We induced Myo5p-GST expression with a 1-h pulse of galactose. During a 90-min chase without galactose, wild-type cells produce a small amount of additional Myo5p-GST (20%), but Myo5p-GST declined rapidly in she4⌬ cells with a half-life of Ϸ30 min (Fig. 6C) . Because wild-type and she4⌬ cells synthesized the same amount of Myo5-GST during the 1-h pulse, and because the steady-state level of Myo5-GST is 10-fold lower in she4⌬ cells, the half life of Myo5p is Ͼ5 h in wild-type cells.
The concentration of Myo5p-GFP expressed from the native genomic promoter was much lower in the cytoplasm and cortical actin patches of she4⌬ cells than wild-type cells (Fig. 5 A-C) . Nevertheless, the lifetimes of Myo5p in patches were Ϸ15 sec in both she4⌬ and wild-type cells (Fig. 5D) .
Myo5p divided almost equally between the soluble and insoluble fractions of wild-type cells lysed in the presence of high salt and ATP (Fig. 5 G and H) . Compared with wild-type cells, Myo5p from she4⌬ cells was reduced Ϸ10-fold in the soluble fraction and Ϸ2-fold in the insoluble fraction (Fig. 5 G and H) . Crude Myo5p-GST enriched from the soluble fraction of wildtype and she4⌬ cells had similar ATPase activities (Table S2) .
Myo5p purified from she4⌬ cells (Fig. 6A ) had slightly higher actin-activated ATPase activity (Fig. 6B and Table S3 ) and supported actin filament gliding at higher rates than Myo5p isolated from wild-type cells by Sun et al. (19) or ourselves (Table  S3) . We obtained sufficient Myo5p for these assays by overexpressing both the MYO5 heavy chain (from a genomic GAL1 promoter) and the Myo5p light chain calmodulin (20) fused to a GST tag (from a plasmid with the GAL1 promoter) in wild-type and she4⌬ cells. Overexpression and 1-step purification of Myo5p/GST-Cmd1p from both wild-type and she4⌬ backgrounds yielded soluble Myo5p (Fig. 6A) . Given that fully functional Myo5p can be recovered from she4⌬ cells, She4p is not essential for de novo folding of the Myo5p motor.
We tested whether increasing the rate of Myo5p synthesis can compensate for the rapid degradation of the protein in the absence of She4p. Overexpression of Myo5p failed to suppress the temperature-sensitivity of she4⌬ cells or alter wild-type cells (Fig. 6 D and E) .
Discussion
Role of UCS Proteins in Myosin Folding and Stability. Because one can isolate Myo5p with robust ATPase and motor activity from budding yeast cells lacking UCS proteins, a UCS protein is not absolutely essential for this myosin-I to fold de novo in the cell. However, the steady-state concentration of Myo5p is 10-fold lower in cells lacking a UCS protein, similar to decreased levels of myosin-II in the body wall muscle of a C. elegans UNC-45 mutant strain (4), or in fission yeast cell extracts derived from a myo2-E1 rng3-65 double mutant (21) . The reduced steady-state concentration of Myo5p is due to rapid degradation of newly synthesized Myo5p in the absence of She4p. Therefore, the budding yeast UCS protein She4p helps to maintain the steadystate levels of myosin in vivo, either by helping Myo5p to fold before it is degraded or inhibiting the degradation of folded Myo5p. The available data do not exclude either mechanism, although we note that a fraction of newly synthesized native Myo5p folds into a fully active motor protein in the absence of a UCS protein. She4p may protect Myo5p from rapid degradation by ubiquitin-mediated proteolysis given that Myo2p (Fig. 5) and C. elegans myosin-II (4) are ubiquitinated. Like Myo5p, the Myo2p motor unlikely requires a UCS protein to fold because Myo2p motors are soluble in budding yeast cells lacking She4p (22) or fission yeast cells defective in Rng3p function (Fig. 4) .
If the sole function of She4p were simply to stabilize myosin levels in the cell, then increasing the rate of Myo5p synthesis by overexpressing its mRNA might offset rapid degradation and rescue the growth defects and temperature-sensitive endocytosis defects of she4⌬ cells. However, overexpression of Myo5p failed . Genomic integration at the MYO5 locus was used to generate MYO5-GFP and MYO5-GST strains. Spinning disk confocal fluorescence microscopy of live wild-type (MLY 701) and she4⌬ (MLY 724) budding yeast cells expressing Myo5p-GFP was used to generate images, which were analyzed using Image J software. Cells were mounted on 25% gelatin pads in CSM medium. Still or time-lapse images were recorded in stacks of 12 confocal z sections (at intervals of 0.5 m) and projected at maximum intensity. Relative levels of Myo5-GST recovered from wild-type (MLY 697) and she4⌬ (MLY 720) cells were estimated by densitometry of Myo5-GST bands, using Image J software. Myo5p-GST bands were detected by using anti-GST antibodies after immunoblotting of SDS/PAGE gels containing glutathione Sepharoseenriched or fractionated cell lysate samples. to suppress the temperature-sensitivity of she4⌬ cells (Fig. 6 D  and E) . This might be due to She4p being required to stabilize other proteins. However, suppressor mutations in MYO5 can rescue the growth defects of she4⌬ cells (8) , so the temperaturesensitive she4⌬ phenotype largely reflects a loss of myosin-I function. The failure of Myo5p overexpression to compensate for its rapid degradation in she4⌬ cells suggests that She4p supports Myo5p function in more than one way, such as promoting association of Myo5p with actin filaments. The phenotype of fission yeast cells with the temperature sensitive rng3-65 mutation is also difficult to reconcile with Rng3p being required only for folding Myo2. Given that very low levels of Myo2 activity suffice for cytokinesis (10) Myo2 would have to degrade very rapidly at the restrictive temperature in rng3-65 cells for the failure of cytokinesis to be explained by insufficient Myo2 alone. (Fig. 1 A) and mature contractile rings (9, 10) , and She4p concentrates with Myo5p in cortical actin patches (7) that turn over in Ϸ15 sec. It seems unlikely that these transient structures are sites of myosin folding, so colocalization suggests that the UCS proteins act on folded myosins as they perform their cellular roles. Note, however, that in the whole cell and in the contractile ring, the number of Myo2 molecules exceeds molecules of Rng3p by about a factor of four (11), so some myosin-II proteins are not associated with Rng3p. Because Myo5p isolated from she4⌬ cells has robust activity, we do not yet know whether She4p promotes the physiological activities of folded Myo5p.
Are UCS Proteins Required for Myosin
Mechanism of Action of Rng3p. Both the central and UCS domains of Rng3p are essential for cellular function. Despite their lack of independent function in vivo, the separate domains both accumulate in the contractile ring. Thus, function requires more than association of the UCS domain with Myo2. The central domain interacts directly with either Myo2p or Rng3p itself (e.g., by dimerization), and may recruit additional binding partners such as Hsp90 (21) .
More Rng3p UCS domain concentrates in contractile rings than full-length Rng3p. The UCS domain concentrated in both precursor nodes and contractile rings, whereas Rng3p only concentrated in mature rings. This property may reflect a role for the central domain in regulating the association of the UCS domain with Myo2.
Full-length Rng3p, but not the UCS domain alone, promotes binding of Myo2 to actin filaments in physiological concentrations of ATP in both in vitro motility and ATPase assays (Fig. 3) . This effect was most striking in motility assays with millimolar ATP, where Rng3p promoted actin filament binding and gliding motility by Myo2. The ability of Rng3p to promote motility does not reflect a role in preventing motor aggregation and loss of function, because low Myo2 concentrations bound actin filaments in the absence of ATP and Rng3p.
Rng3p likely interacts with the head of Myo2 but also seems to depend on the tail to promote motility. Rng3p promotes the , and she4⌬ GAL1promoter-MYO5 (MLY 758) cells. All three strains contained a plasmid (pPGAL1-GST-CMD1-TRP1 or pPGAL1-GST-CMD1-URA3) expressing GST-Cmd1p from the galactose-inducible promoter. Protein was enriched by one-step purification on glutathione Sepharose. Outside gel lanes show molecular mass markers (kDa). (B) Actin-activated ATPase activity of Myo5p plotted as a function of polymerized actin concentration. Myo5p was purified in one step (as described in A) from wild-type and she4⌬ cells. The concentration of Myo5p in these impure samples was estimated by using densitometry measurements of Coomassie-stained protein bands with rabbit skeletal muscle myosin as the standard. Basal Myo5p ATPase activities were subtracted from all rates derived in the presence of polymerized actin (1-120 M). All assays included Myo5p at a final concentration of 50 -75 nM in 2 mM Tris⅐HCl (pH 7.2), 10 mM imidazole, 100 mM KCl, 0.1 mM CaCl 2, 3 mM MgCl2, 2 mM ATP, and 1 mM DTT. For each curve, two separate datasets were averaged and displayed as a single dataset fit to Michaelis-Menten kinetics, using KaleidaGraph software. (C) Pulse-chase experiment on the biosynthesis and turnover of Myo5p-GST. Wild-type (MLY 801, PGAL1-MYO5-GST) and she4⌬ (MLY 802, she4⌬ PGAL1-MYO5-GST) cells were grown in rich media containing 1% raffinose before induction of Myo5p-GST expression by addition of 2% galactose for 1 h. Cells were harvested and Myo5p-GST expression repressed by growth in rich media containing 2% glucose. Cell samples were taken before induction (Raff), after induction for 1 h (0) and at time points 15-90 min after initiating repression. Equal amounts of soluble protein in total cell extracts were separated by SDS/PAGE and analyzed by immunoblotting with antibodies to GST. The 155-kDa band is the size expected for Myo5p-GST. actin-activated ATPase of Myo2-head-GST, but not the ability of Myo2-head-GST to support motility. We note that Rng3p reduced the K ATPase for actin filaments from 10 to 5 M for Myo2 and from 30 to 14 M for Myo2-head-GST (Table S4) . Thus, even with Rng3p, the apparent affinity of Myo2-head-GST for actin filaments may fall short of an affinity threshold required for motility. Alternatively, the ability of Myo2 to form filaments containing multiple motors may be needed for Rng3p to potentiate actin filament binding in motility assays. The latter possibility may explain why UCS proteins colocalize with myosin-II assembled in fission yeast contractile rings (9, 10) and C. elegans body wall muscle (4).
Methods
Yeast Strains, Growth Conditions, and Cell and Genetic Methods. We used standard methods described in SI Methods to grow yeast and modify their genomes. Table S4 lists fission and budding yeast strains used in this study. Table S5 lists fission and budding yeast plasmids.
Microscopy.
We imaged yeast strains expressing GFP fusion proteins by spinning disk confocal or epi-fluorescence microscopy and processed the images with MetaMorph, UltraView RS, Image J, and PhotoShop software.
Protein Purification. Details on protein purifications and biochemical assays are provided in the SI Methods. Briefly, full-length Myo2 (Myo2p/Cdc4p/Rlc1p) was purified as described in ref. 10 . We purified GST-tagged myosin constructs from budding and fission yeast by affinity chromatography and additional steps. We purified actin from rabbit skeletal muscle for ATPase and in vitro motility assays (10) . SI Methods provides additional details about gel electrophoresis and immunoblots (10) . We used a pulse-chase experiment to determine the stability of Myo5p-GST in budding yeast. Adding 2% galactose to the medium for 1 h induced a pulse of expression, after which we observe the amount of Myo5p-GST in extracts on immunoblots over time. Tables S1, S2 , and S3 summarize the biochemical activities of purified Myo2, Myo2-head-GST and Myo5p. For temperature-shift experiments with the fission yeast sid2-250 ts strain and wild-type controls, cells growing exponentially in rich liquid media to an OD 595 of 0.1 at 25°C were transferred to 36°C for 3-4 h of growth. Complementation of the fission yeast rng3-65 ts strain using rng3 constructs was tested by streaking ura ϩ plasmid transformants on EMM-Ura Ϫ minimal media plates, which were then grown at 25°C. Cells were restreaked and grown at the restrictive condition (36°C). For localization experiments rng3-65 transformants were grown exponentially at 25°C in EMM-Ura Ϫ minimal media.
Supporting Information
GFP fusion proteins and stains were imaged in cells as described in refs. 3 and 5. Images were acquired and processed using MetaMorph, UltraView RS, Image J, and PhotoShop software. Subcellular Myo5p-GFP fluorescence intensities and lifetimes (in patches) were measured in ImageJ by analysis of single and time-lapse micrographs recorded at intervals of 2 sec.
Plasmids. Table S1 lists fission and budding yeast plasmids. The fidelity of all DNA sequences was confirmed by automated sequencing. Where necessary, the orientation of inserts was confirmed by diagnostic restriction analysis. p3xGFP. DNA encoding triple GFP was amplified from pFA6a-3xGFP-kanMX6 with the primers: 5Ј XhoI CTCGAGGGAA-CAAAAGCTGGAGGATCC and 3Ј NotI GCGGCCGCAGA-TATTAAAGAATACAGATCTTTGTTTGTACA. The DNA was ligated into pDS573a (harboring the weak-strength 81-nmt1 inducible promoter) at the XhoI and NotI sites yielding a construct with an N-terminal 3xGFP tag. p3xGFP-rng3/UCS/central. The rng3 ORF and DNA encoding the Rng3p UCS domain were liberated from pGST-rng3-FL and pGST-rng3-UCS (3) respectively and ligated into p3xGFP at the NotI site. DNA encoding the N-terminal ''central'' domain (bp 1-996) of Rng3p was amplified using the primers: 5Ј NotI GCGGCCGCATGACCCACGAGCTTTCCTCAAC and 3Ј NotI GCGGCCGCTCAAATAACTTGAGAAAGCTGGT-ACTG. The DNA fragment was ligated into p3xGFP at the NotI site. pDS473-LEU2-rlc1. The rlc1 ORF was liberated from pDS473-rlc1 (3) by SalI digestion and transferred to pDS473-LEU2 cut with SalI. pDS472a-myo2-head. Base pairs 1-2445 of myo2 were amplified from genomic DNA using the primers: 5Ј NotI GCGGCCGCG-GCGGTGGA ATGACAGA AGTA ATATCTA ATA A A A-TAACTGC and 3Ј NotI GCGGCCGCCGGGCCTTAGATT-GAAAAATAACTTAGC. The fragment was ligated into pDS472a at the NotI site to generate an overexpression construct encoding the motor and light chain-binding domain of Myo2p fused at its C terminus to GST (lacking a thrombin cleavage site). pPGAL1-GST-TRP1. The MYO1 promoter fragment from pPGT (5) was liberated by digestion with KpnI and XhoI and replaced with a fragment containing the budding yeast GAL1 promoter, which was amplified from pFA6a-kanMX6-PGAL1with primers 5Ј KpnI GGTACCGTAAAGAGCCCCATTATCTTAGC and 3Ј XhoI CTCGAGT T TGAGATCCGGGTTTTTTCTCCT T-GAC. The XhoI/NotI GFP-encoding fragment was then replaced with the XhoI/NotI GST-encoding fragment taken from pDS473a. pPGAL1-GST-URA3. The GAL1 promoter-GST-MYO1 terminator cassette from pPGAL1-GST-TRP1 was liberated by KpnI/SacI digestion and ligated into pRS316 at the KpnI and SacI sites. pPGAL1-GST-CMD1-TRP1, pPGAL1-GST-CMD1-URA3. The budding yeast calmodulin ORF (CMD1) was amplified from genomic DNA using the primers: 5Ј NotI GCGGCCGCGGTGGAGGTAT-GTCCTCCAATCTTACCGAAG and 3Ј SalI GTCGAC-CTATTTAGATAACAAAGCAGCGAATTG. CMD1 was then ligated into both pPGAL1-GST-TRP1 and pPGAL1-GST-URA3 using NotI and SalI sites.
Protein Purification. Myo2/Myo2-head/Rng3p/Rng3p UCS domain. Myo2 (full-length Myo2p and its light chains, Cdc4p and Rlc1p), GST-Rng3p, and GST-Rng3p UCS domain (GST-UCSp) were purified as described in ref. 3 . We used a strategy similar to that used for Myo2 to purify Myo2-head-GST, a truncated form of Myo2p (amino acids 1-815) with a C-terminal GST tag. We co-overexpressed Myo2-head-GST with GST-tagged light chains, using the nmt1 promoter in MLP 479 cotransformed with either (i) pDS472a-myo2-head and pDS473-LEU2-cdc4 or (ii) pDS472a-myo2-head and pDS473-LEU2-rlc1. Transformants were grown to saturation in liquid EMM Ura Ϫ Leu Ϫ medium (plus thiamine) and harvested. Cells were washed three times in EMM Ura Ϫ Leu Ϫ medium (lacking thiamine) before resuspending in 4 liters of the same medium yielding a starting OD 595 of 0.05. Myo2-head-GST and light chain overexpression were induced during growth at 32°C for 24 h. Cultures (a and b) were combined and harvested. Pellets were resuspended 1:1 in Lysis Buffer [750 mM KCl, 25 mM Tris⅐HCl (pH 7.4), 4 mM MgCl 2 , 4 mM ATP, 20 mM sodium pyrophosphate, 2 mM EGTA, 1 mM DTT, 2 mM PMSF, 0.1% Triton X-100, plus EDTA-free protease inhibitors (Roche)] and lysed with a Microfluidizer (model M-110S; Microfluidics). Myo2p-head-GST/GST-Cdc4p/GSTRlc1p was recovered from lysates by enriching on glutathioneSepharose, followed by thrombin cleavage to remove GST from the light chains. The sample was dialyzed into S1 Buffer [2 mM Tris⅐HCl (pH 7.0), 0.1 mM CaCl 2 , 10 mM imidazole, 50 mM KCl, 1 mM MgCl 2 , and 1 mM DTT] and further purified by two actin pelleting steps: (i) Myo2-head-GST was incubated (Ϸ1:5) with hexokinase-treated actin filaments (3) and centrifuged at 100,000 ϫ g for 2 h; and (ii) the pellet was resuspended in S1 buffer plus 2 mM ATP and spun again to separate actin in the pellet from dissociated Myo2-head-GST in the supernatant. Contaminating actin was removed by a second affinity step with glutathione Sepharose to yield purified Myo2-head-GST. The concentration of Myo2-head-GST was estimated by densitometry of Coomassie-stained bands after SDS/PAGE, using rabbit skeletal muscle myosin as the standard. Myo5p. Haploid budding yeast strains in which genomic MYO5 gene was replaced with MYO5-GST (MLY 697, 720) were grown in 2-liter of YPDa to an OD 595 of 3. A control strain (JC 1284) in which MYO5 was untagged was cultured in a similar fashion. To overexpress Myo5p, MLY 745 and MLY 758 (strains with the genomic MYO5 promoter replaced with the GAL1 promoter) were transformed with pPGAL1-GST-URA3-CMD1 and pP-GAL1-GST-TRP1-CMD1 respectively. A control lacking a GAL1 promoter upstream of MYO5 (Y 258 transformed with pPGAL1-GST-URA3-CMD1) was included. Cells were grown in 2-liter of CSM-Ura -(MLY 745, Y 258) or CSM-Trp -(MLY 758) with 1% raffinose as the sole carbon source. Once cultures reached an OD595 of 0.3, overexpression was induced by addition of 2% galactose and further growth for 12 h. Cells were harvested and lysed as described in the Myo2-head-GST purification. Native Myo5-GST and overexpressed GST-Cmd1p (and accompanying Myo5p) were partially purified by binding to and elution from glutathione-Sepharose and then dialyzed vs. 0.5 M KCl, 10 mM imidazole, pH 7.0, and 1 mM DTT. The concentration of Myo5p generated by overexpression was estimated by densitometry of Coomassie-stained bands after SDS/PAGE using rabbit skeletal muscle myosin as the standard. Skeletal muscle actin and myosin. Actin was purified from rabbit skeletal muscle acetone powder (6) . Actin filaments were formed by addition of 50 mM KCl and 1 mM MgCl 2 . Fluorescent actin filaments were prepared for motility assays by polymerizing 5 M actin in 5 M rhodamine-phalloidin. Rabbit skeletal muscle myosin was purified as described in ref. 7 . Table S1 . ATPase and in vitro motility activities of Myo2-head-GST and Myo2 ATPase activities are shown as nanomoles of ATP hydrolyzed per minute per milligram of protein (nmol⅐min Ϫ1 ⅐mg Ϫ1 ). Samples were generated by enriching Myo5-GST from soluble cell extracts of JC 1284 (wild type), MLY 697 (MYO5-GST), and MLY 720 (she4⌬ MYO5-GST). Values reflect averages generated from two independent experiments using different segregants. Numbers given in parentheses represent normalized activities accounting for the relative levels of soluble Myo5-GST enriched from wild-type and she4⌬ strains (see Fig. 5F ). *Activity measured using a final concentration of 15 M actin filaments. in vitro motility activities for budding yeast myosin-I (Myo5p) 
